HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CTX-M-9 group ESBL-producing Raoultella planticola nosocomial infection: first report from sub-Saharan Africa.

AbstractBACKGROUND:
Raoultella are Gram-negative rod-shaped aerobic bacteria which grow in water and soil. They mostly cause nosocomial infections associated with surgical procedures. This case study is the first report of a Raoultella infection in Africa. Case presentation We report a case of a surgical site infection (SSI) caused by Raoultella planticola which developed after caesarean section (CS) and surgery for secondary small bowel obstruction. The patient became febrile with neutrophilia (19,157/µL) 4 days after laparotomy and started to develop clinical signs of a SSI on the 8th day after laparotomy. The patient continued to be febrile and became critically ill despite empirical treatment with ceftriaxone and vancomycin. Raoultella species with extended antimicrobial resistance (AMR) carrying the CTX-M-9 β-lactamase was isolated from the wound discharge. Considering the antimicrobial susceptibility test, ceftriaxone was replaced by ceftazidime. The patient recovered and could be discharged on day 29 after CS.
CONCLUSIONS:
Raoultella planticola was isolated from an infected surgical site after repeated abdominal surgery. Due to the infection the patient's stay in the hospital was prolonged for a total of 4 weeks. It is noted that patients undergoing surgical and prolonged inpatient treatment are at risk for infections caused by Raoultella. The development of a SSI caused by Raoultella planticola with extended AMR has to be assumed to be a consequence of ineffective antibiotic utilization. The presented case advices that rare bacteria as Raoultella should be considered as potential cause of nosocomial SSI with challenging treatment due to high levels of AMR.
AuthorsTafese Beyene Tufa, Andre Fuchs, Torsten Feldt, Desalegn Tadesse Galata, Colin R Mackenzie, Klaus Pfeffer, Dieter Häussinger
JournalAnnals of clinical microbiology and antimicrobials (Ann Clin Microbiol Antimicrob) Vol. 19 Issue 1 Pg. 36 (Aug 17 2020) ISSN: 1476-0711 [Electronic] England
PMID32807201 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Ceftazidime
  • beta-Lactamases
Topics
  • Adolescent
  • Africa South of the Sahara
  • Anti-Bacterial Agents (therapeutic use)
  • Ceftazidime (therapeutic use)
  • Cross Infection (drug therapy, microbiology)
  • Drug Resistance, Multiple, Bacterial
  • Enterobacteriaceae (isolation & purification)
  • Enterobacteriaceae Infections (diagnosis, drug therapy, microbiology)
  • Female
  • Humans
  • Laparotomy (adverse effects)
  • Pregnancy
  • Surgical Wound Infection (drug therapy, microbiology)
  • beta-Lactamases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: